Page last updated: 2024-08-26

arsenic and Duncan Disease

arsenic has been researched along with Duncan Disease in 3 studies

Research

Studies (3)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's3 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Bobé, P; Chelbi-Alix, MK1
Colomer, D; Montserrat, E; Villamor, N1
Benihoud, K; Bobé, P; Bonardelle, D; Chelbi-Alix, MK; Opolon, P1

Reviews

1 review(s) available for arsenic and Duncan Disease

ArticleYear
Cytotoxic effects of B lymphocytes mediated by reactive oxygen species.
    Current pharmaceutical design, 2004, Volume: 10, Issue:8

    Topics: 2-Methoxyestradiol; Animals; Antibodies, Monoclonal; Antibodies, Monoclonal, Murine-Derived; Antigens, CD20; Antineoplastic Agents; Arsenic Trioxide; Arsenicals; B-Lymphocytes; Benzodiazepines; Cell Death; Estradiol; Hexanones; Humans; Lymphoproliferative Disorders; Oxidative Stress; Oxides; Reactive Oxygen Species; Rituximab; Signal Transduction

2004

Other Studies

2 other study(ies) available for arsenic and Duncan Disease

ArticleYear
[New therapeutic perspectives for arsenic: from acute promyelocytic leukemia to autoimmune diseases].
    Medecine sciences : M/S, 2008, Volume: 24, Issue:11

    Topics: Animals; Antineoplastic Agents; Arsenic; Arsenic Trioxide; Arsenicals; Autoimmune Diseases; Disease Models, Animal; Growth Inhibitors; Humans; Leukemia, Promyelocytic, Acute; Lupus Erythematosus, Systemic; Lymphoproliferative Disorders; Mice; Oxides

2008
Arsenic trioxide: A promising novel therapeutic agent for lymphoproliferative and autoimmune syndromes in MRL/lpr mice.
    Blood, 2006, Dec-15, Volume: 108, Issue:13

    Topics: Animals; Antibodies, Antinuclear; Antigen-Antibody Complex; Antineoplastic Agents; Apoptosis; Arsenic Trioxide; Arsenicals; Caspases; Cytokines; Drug Evaluation, Preclinical; Enzyme Activation; fas Receptor; Glutathione; Humans; Lupus Erythematosus, Systemic; Lymphocyte Activation; Lymphoproliferative Disorders; Mice; Mice, Inbred MRL lpr; Nitric Oxide; Oxidation-Reduction; Oxides; Syndrome

2006